$250B Cencora Names Pawan Verma Chief Data And Information Officer
Global pharmaceutical company Cencora, Inc. recently announced the appointment of Pawan Verma as Executive Vice President and ...
Biogen, Eisai Win CHMP Backing of Leqembi Alzheimer's Drug
A key European regulatory panel has reversed course and is now recommending approval of Leqembi, the Alzheimer's drug from Biogen and Eisai. The companies on Thursday said the European Medicines ...
Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
BioSpace13h
GSK Builds Case for Blenrep with Multiple Myeloma OS Data That Bests J&J’s Darzalex
GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects a multi-blockbuster ...
After a break from acquisitions, Avantor is getting ready to break out its M&A playbook again
Historically an active player in the M&A space, Radnor-based Avantor has not found itself so busy in that realm during the ...
OmniAb’s Robust Pipeline and Strategic Positioning Drive Buy Rating Despite Macroeconomic Challenges
Leerink Partners analyst Puneet Souda maintained a Buy rating on OmniAb (OABI – Research Report) on November 12 and set a price target of ...
Zentalis Pharmaceuticals Announces New Leadership and Strategy Shift
The latest announcement is out from Zentalis Pharmaceuticals ( (ZNTL) ). Zentalis Pharmaceuticals is undergoing significant leadership changes ...